Cargando…
Identification of Two DNMT3A Mutations Compromising Protein Stability and Methylation Capacity in Acute Myeloid Leukemia
Somatic mutations of DNMT3A occur in about 20% of acute myeloid leukemia (AML) patients. They mostly consist in heterozygous missense mutations targeting a hotspot site at R882 codon, which exhibit a dominant negative effect and are associated with high myeloblast count, advanced age, and poor progn...
Autores principales: | Bruno, Samantha, Bochicchio, Maria Teresa, Franchini, Eugenia, Padella, Antonella, Marconi, Giovanni, Ghelli Luserna di Rorà, Andrea, Venturi, Claudia, Raffini, Maddalena, Prisinzano, Giovanna, Ferrari, Anna, Bandini, Lorenza, Robustelli, Valentina, Pazzaglia, Martina, Fontana, Maria Chiara, Sartor, Chiara, Abbenante, Maria Chiara, Papayannidis, Cristina, Soverini, Simona, Ottaviani, Emanuela, Simonetti, Giorgia, Martinelli, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881567/ https://www.ncbi.nlm.nih.gov/pubmed/31827512 http://dx.doi.org/10.1155/2019/5985923 |
Ejemplares similares
-
Prexasertib, a Chk1/Chk2 inhibitor, increases the effectiveness of conventional therapy in B-/T- cell progenitor acute lymphoblastic leukemia
por: Rorà, Andrea Ghelli Luserna Di, et al.
Publicado: (2016) -
Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies
por: Padella, Antonella, et al.
Publicado: (2022) -
Loss of PALB2 predicts poor prognosis in acute myeloid leukemia and suggests novel therapeutic strategies targeting the DNA repair pathway
por: Padella, Antonella, et al.
Publicado: (2021) -
Pharmacological Inhibition of WIP1 Sensitizes Acute Myeloid Leukemia Cells to the MDM2 Inhibitor Nutlin-3a
por: Fontana, Maria Chiara, et al.
Publicado: (2021) -
CDC20 in and out of mitosis: a prognostic factor and therapeutic target in hematological malignancies
por: Bruno, Samantha, et al.
Publicado: (2022)